DNA-protein interactions are central to the life cycle of all of the Herpes viruses. Herpes Simplex type 1 ICP8 protein is a delayed early protein that binds DNA and has been implicated in multiple stages of HSV DNA metabolism. It was recently discovered in this laboratory that ICP8 will catalyze DNA strand transfer reactions. Lehman and colleagues have shown that the HSV origin binding protein, UL-9, has a potent helicase activity in the presence of ICP8, and that it forms a heterodimer with ICP8 consisting of one monomer of ICP8 and one monomer of UL-9. In this project a major focus will be on further characterizing the interactions of ICP8, UL-9, an the human single strand binding protein, RPA in their catalysis of basic DNA transactions. A major tool of this study will be electron microscopy (EM). Previous preparations of ICP8 contained a small amount of residual exonuclease activity. Here ample quantities of ICP8 will be purified from HSV-infected cells to a level where the nuclease can either be eliminated totally or shown to be an integral part of ICP8. RPA will be purified from human cells and UL-9 will be obtained via collaboration. Alternatively new Baculovirus preparations of ICP8 may provide active material. In the best characterized systems, a single strand DNA binding protein is required as a co-factor for the strand transferases. RPA binds single strand DNA (ssDNA) tightly and HSV proteins will encounter RPA in the ell. Interactions between ICP8 and phosphorylated forms of RPA will be examined to determine if RPA will stimulate ICP8 or inhibit its activities. In a continuing collaboration the interaction of purified UL-9 protein with the HSV origin (ori-s) will be examined. This EM study will focus on binding sites, how the DNA is arranged by UL-9, whether RPA or ICP8 will facilitate the opening of the origin by UL-9, and finally how ICP8 promotes the helicase activity of UL-9. Much work is needed to further characterize the strand transfer properties of iCP8. This will employ ICP8, RPA, and UL-9 and use EM and biochemical assays. The preference of ICP8 for different DNA templates, whether it will catalyze exchange on nucleosomal DNA, and whether it will catalyze exchange at nicks or gaps in DNA will be examined. DNA templates will be designed to test the hypothesis that iCP8 and UL-9 can create structures that will prime secondary rounds of DNA replication.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Program Projects (P01)
Project #
5P01CA019014-21
Application #
6101875
Study Section
Project Start
1998-05-01
Project End
1999-09-29
Budget Start
1997-10-01
Budget End
1998-09-30
Support Year
21
Fiscal Year
1998
Total Cost
Indirect Cost
Name
University of North Carolina Chapel Hill
Department
Type
DUNS #
078861598
City
Chapel Hill
State
NC
Country
United States
Zip Code
27599
DeKroon, Robert M; Gunawardena, Harsha P; Edwards, Rachel et al. (2018) Global Proteomic Changes Induced by the Epstein-Barr Virus Oncoproteins Latent Membrane Protein 1 and 2A. MBio 9:
Nicholls, Thomas J; Nadalutti, Cristina A; Motori, Elisa et al. (2018) Topoisomerase 3? Is Required for Decatenation and Segregation of Human mtDNA. Mol Cell 69:9-23.e6
El-Mallawany, Nader Kim; Kamiyango, William; Villiera, Jimmy et al. (2018) Proposal of a Risk-Stratification Platform to Address Distinct Clinical Features of Pediatric Kaposi Sarcoma in Lilongwe, Malawi. J Glob Oncol :1-7
Selitsky, Sara R; Marron, David; Mose, Lisle E et al. (2018) Epstein-Barr Virus-Positive Cancers Show Altered B-Cell Clonality. mSystems 3:
Hosseinipour, Mina C; Kang, Minhee; Krown, Susan E et al. (2018) As-Needed Vs Immediate Etoposide Chemotherapy in Combination With Antiretroviral Therapy for Mild-to-Moderate AIDS-Associated Kaposi Sarcoma in Resource-Limited Settings: A5264/AMC-067 Randomized Clinical Trial. Clin Infect Dis 67:251-260
Lyons, Danielle E; Yu, Kuan-Ping; Vander Heiden, Jason A et al. (2018) Mutant Cellular AP-1 Proteins Promote Expression of a Subset of Epstein-Barr Virus Late Genes in the Absence of Lytic Viral DNA Replication. J Virol 92:
Bigi, Rachele; Landis, Justin T; An, Hyowon et al. (2018) Epstein-Barr virus enhances genome maintenance of Kaposi sarcoma-associated herpesvirus. Proc Natl Acad Sci U S A 115:E11379-E11387
El-Mallawany, Nader Kim; Villiera, Jimmy; Kamiyango, William et al. (2018) Endemic Kaposi sarcoma in HIV-negative children and adolescents: an evaluation of overlapping and distinct clinical features in comparison with HIV-related disease. Infect Agent Cancer 13:33
Kobayashi, E; Aga, M; Kondo, S et al. (2018) C-Terminal Farnesylation of UCH-L1 Plays a Role in Transport of Epstein-Barr Virus Primary Oncoprotein LMP1 to Exosomes. mSphere 3:
Hopcraft, Sharon E; Pattenden, Samantha G; James, Lindsey I et al. (2018) Chromatin remodeling controls Kaposi's sarcoma-associated herpesvirus reactivation from latency. PLoS Pathog 14:e1007267

Showing the most recent 10 out of 324 publications